Bacteriostatic Sodium Chloride 0.9% In Plastic Container

   
Google
 
Web NewDrugInformation.com

Bacteriostatic Sodium Chloride 0.9% In Plastic Container


Drug - Bacteriostatic Sodium Chloride 0.9% In Plastic Container
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Sodium Chloride
Multiple ingredients are in alphabetical order.

Strength - 9MG/ML
The potency of the active ingredient(s), Sodium Chloride. May repeat for multiple part products.

Applicant - HOSPIRA
The firm name holding legal responsibility for Bacteriostatic Sodium Chloride 0.9% In Plastic Container. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018800
The FDA assigned number to Bacteriostatic Sodium Chloride 0.9% In Plastic Container. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Bacteriostatic Sodium Chloride 0.9% In Plastic Container. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 29, 1982
The date Bacteriostatic Sodium Chloride 0.9% In Plastic Container was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Bacteriostatic Sodium Chloride 0.9% In Plastic Container. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Bacteriostatic Sodium Chloride 0.9% In Plastic Container is in. Format is RX, OTC, DISCN.

Applicant Full Name - Hospira Inc
The full name of the firm holding legal responsibility for the new application of Bacteriostatic Sodium Chloride 0.9% In Plastic Container.

Bacteriostatic Sodium Chloride 0.9% In Plastic Container


Sodium Bicarbonate In Plastic Container 1meq/ml **federal Register Determination That Product Was Not Discontinued Or Withdrawn For Safety Or Efficacy Reasons** Injectable; Injection
Baros 460mg/gm;420mg/gm Granule, Effervescent; Oral
Broncho Saline 0.9% Aerosol, Metered; Inhalation
Bacteriostatic Sodium Chloride 0.9% In Plastic Container 9mg/ml Injectable; Injection
Bacteriostatic Sodium Chloride 0.9% In Plastic Container 9mg/ml Injectable; Injection
Bacteriostatic Sodium Chloride 0.9% In Plastic Container 9mg/ml Injectable; Injection
Ucephan 100mg/ml;100mg/ml Solution; Oral
Sodium Bicarbonate 0.9meq/ml Injectable; Injection
Sodium Bicarbonate 1meq/ml Injectable; Injection
Sodium Bicarbonate In Plastic Container 0.9meq/ml **federal Register Determination That Product Was Not Discontinued Or Withdrawn For Safety Or Efficacy Reasons** Injectable; Injection

NewDrugInformation